BRIEF-Surmodics reports Q1 non-GAAP earnings per share $0.19

* Surmodics Inc says remain on track to continue clinical evaluation of our surveil drug-coated balloon
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.